Discrepancy between ultrasonography and hysteroscopy and histology of endometrium in postmenopausal breast cancer patients using tamoxifen

Gynecologic Oncology

Volumn 73, Issue 1, 1999, Pages 21-26

  Mourits, Marian J E ^a   Van Der Zee, Ate G J ^a   Willemse, Pax H B ^a   Ten Hoor, Klaske A ^a   Hollema, Harry ^a   De Vries, Elisabeth G E ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER SCREENING; DIAGNOSTIC VALUE; ENDOMETRIUM ATROPHY; ENDOMETRIUM CARCINOMA; FEMALE; HISTOPATHOLOGY; HUMAN; HYSTEROSCOPY; MAJOR CLINICAL STUDY; POLYP; POSTMENOPAUSE; PRIORITY JOURNAL; THICKNESS; TRANSVAGINAL ECHOGRAPHY;

EID: 0032945740     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1998.5316     Document Type: Article

References (32)

1. Boccardo F, Bruzzi P, Rubagotti A, et al.: Estrogen-like action of tamoxifen on vaginal epithelium in breast cancer patients. Oncology 38:281-285, 1980
2. Powles TJ, Jones AL, Ashley SE, et al.: The Royal Marsden Hospital pilot tamoxifen chemoprevention trial. Breast Cancer Res Treat 31:73-82, 1994
3. Lahti E, Blanco G, Kauppila A, et al: Endometrial changes in postmenopausal breast cancer patients receiving tamoxifen. Obstet Gynecol 81: 660-664, 1993
4. Fornander T, Rutqvist IE, Cedermark B, et al.: Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers. Lancet 19:117-120, 1989
5. Andersson M, Strom HH, Mouridson HT: Incidence of new primary cancers after adjuvant tamoxifen therapy and radiotherapy for early breast cancer. J Natl Cancer Inst 83:1013-1017, 1991.
6. Fisher B, Constantino JP, Redmond CK, et al: Endometrial cancer in tamoxifen treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14. J Natl Cancer Inst 86:527-537, 1994.
7. Van Leeuwen FE, Benraadt J, Coeberg JWW, et al.: Risk of endometrial cancer following breast cancer treatment with tamoxifen. Lancet 343:448-452, 1994
8. Rutqvist LE, Johansson H, Signomklao T, et al.: Adjuvant tamoxifen therapy for early breast cancer and second primary malignancies. J Natl Cancer Inst 87:645-651, 1995
9. Sasco AJ, Chaplain G, Amoros E, Saez S: Endometrial cancer following breast cancer: effect of tamoxifen and castration by radiotherapy. Epidemiology 7:9-13, 1996
10. IARC on tamoxifen [news]. Environ Health Perspect 104:688, 1996
11. Hemminki K, Rajaniemi H, Lindahl B, Moberger B: Tamoxifen-induced DNA adducts in endometrial samples from breast cancer patients. Cancer Res 56:4374-4377, 1996
12. Goldstein SR, Nachtigall M, Snyder JR, et al.: Endometrial assessment by vaginal ultrasonography before endometrial sampling in patients with postmenopausal bleeding. Am J Obstet Gynecol 163:119-123, 1990
13. Karlsson B, Granberg S, Wikland M, et al: Transvaginal ultrasonography of the endometrium in women with postmenopausal bleeding - a Nordic multicentered study. Am J Obstet Gynecol 172:1488-1494, 1995
14. Granberg S, Wikland M, Karlsson B, et al.: Endometrial thickness as measured by endovaginal ultrasonography for identifying endometrial abnormality. Am J Obstet Gynecol 164:47-52, 1991
15. Andolf E, Dahlander K, Aspenberg P. Ultrasonic thickness of the endometrium correlated to body weight in asymptomatic postmenopausal women. Obstet Gynecol 82:936-940, 1993
16. Anteby E, Yagel S, Zacut D, et al.: False sonographic appearance of endometrial neoplasia in postmenopausal women treated with tamoxifen. Lancet 340:433-434, 1992 (letter)
17. Goldstein SR: Unusual ultrasonographic appearance of the uterus in patients receiving tamoxifen. Am J Obstet Gynecol 170:447-451, 1994
18. Exacoustos C, Zupi E, Cangi B, et al.: Endometrial evaluation in postmenopausal breast cancer patients receiving tamoxifen: an ultrasound, color flow Doppler, hysteroscopic and histological study. Ultrasound Obstet Gynecol 6:435-442, 1995
19. Hulka CA, Hall DA: Endometrial abnormalities associated with tamoxifen therapy for breast cancer: sonographic and pathologic correlation. Am J Radiol 160:809-812, 1993
20. Cohen I, Rosen D, Teppe R, et al: Ultrasonographic evaluation of the endometrium and correlation with endometrial sampling in postmenopausal patients treated with tamoxifen. J Ultrasound Med 12:275-280, 1993
21. Kedar RP, Bourne TH, Powles TJ, et al.: Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomised breast cancer prevention trial. Lancet 343:1318-1321, 1994
22. Uziely B, Lewin A, Brufman G, et al: The effect of tamoxifen on the endometrium. Breast Cancer Res Treat 26:101-105, 1993
23. Bese T, Kosebay D, Demirkiran F, et al.: Ultrasonographic appearance of endometrium in postmenopausal breast cancer patients receiving tamoxifen. Eur J Obstet Gynecol Reprod Biol 67:157-162, 1996
24. Ferenczy A: Anatomy and histology of the uterine corpus, in Kurman RJ (ed): Blaustein's Pathology of the Female Genital Tract, 3rd edition, New York, Springer Verlag, 1987, pp 257-291
25. Hendrickson MR, Kempson RL: Endometrial hyperplasia, metaplasia and carcinoma, in Fox H (ed): Obstetrical and Gynaecological Pathology, Edinburgh, Churchill Livingstone, 1987, pp 354-362
26. Achiron R, Liptiz S, Sivan E, et al.: Sonohysterography for ultrasonographic evaluation of tamoxifen associated cystic thickened endometrium. J Ultrasound Med 14:685-688, 1995
27. Perrot N, Guyot B, Antoine M, et al.: The effect of tamoxifen on the endometrium. Ultrasound Obstet Gynecol 4:83-84, 1994
28. Decensi V, Fontana V, Bruno S, et al.: Effect of tamoxifen on endometrial proliferation. J Clin Oncol 14:434-440, 1996
29. Ismail SM: Pathology of endometrium treated with tamoxifen. J Clin Pathol 47:827-833, 1994
30. Bourne T, Lawton F, Leather A, et al.: Use of intracavity saline instillation and transvaginal ultrasonography to detect tamoxifen-associated endometrial polyps. Ultrasound Obstet Gynecol 4:73-75, 1994
31. Tepper R, Beyth Y, Altaras MM, et al.: Value of sonohysterography in asymptomatic postmenopausal tamoxifen-treated patients. Gynecol Oncol 64:386-391, 1997
32. Timmerman D, Deprest J, Bourne T, et al.: A randomized trial on the use of ultrasonography or office hysteroscopy for endometrial assessment in postmenopausal patients with breast cancer who were treated with tamoxifen. Am J Obstet Gynecol 179:62-70, 1998.